OrganiGram Holdings lands at 51 on the CIN composite, a Neutral outcome with conviction of 1/5. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Regulatory carries this profile, printing 66 and setting the ceiling on the composite. The editorial pillar sits at 30, and is the main drag on the composite.
The observable inputs tell a straightforward story: reported revenue growth of -8.9 percent year over year, an operating margin of -16.4 percent, gross margin of 35.6 percent, a market cap near 136 million, a filing cadence of 2 regulator events in the trailing 90 days, a jurisdictional posture reading of 80. Every figure is auditable in the accompanying pillar table. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets OrganiGram Holdings be lined up against the global cannabis coverage universe on identical inputs, with refresh cadence tied directly to primary-source ingest.
Filing cadence and jurisdictional posture remain the primary drivers, with regulatory contributing 66. A sustained lift in filing frequency across the trailing 90 days combined with zero enforcement events would tighten the Neutral conclusion.
Bullish and Bearish Analyst Opinions for OrganiGram Holdings (OGI)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for OrganiGram Holdings (OGI), a cannabis-sector equity listed on NASDAQ in the Canadian LP category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Avoid / Capital Risk. Multiple flags: deep drawdown. (0 bullish signals, 3 bearish signals.)
Bullish and bearish analyst opinions for Organigram Global Inc. (OGI)
Bullish view. Organigram Global is one of the cheapest LP names on EV/sales, and its BAT-anchored balance sheet gives it dry powder that most Canadian peers lack.
Bearish view. Bearish views focus on the crowded Canadian rec market, thin gross margins, and the lack of a US catalyst path.
Canadian LP focused on indoor-grown cannabis. Known for premium flower brands and international medical exports.
Latest price: $0.94 (-2.96%) on NASDAQ.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for OGI are maintained by Cannabis Investor News and refreshed throughout the trading day.